BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 20593136)

  • 1. Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management.
    Foo SH; Chan SP; Ananda V; Rajasingam V
    Singapore Med J; 2010 May; 51(5):e89-93. PubMed ID: 20593136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and surgical treatment of extra-adrenal pheochromocytoma].
    Hiller WF; Scheumann GF; Dralle H
    Chirurg; 1993 Jan; 64(1):36-42. PubMed ID: 8436047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative immunohistochemical study of phaeochromocytomas and paragangliomas.
    Fraga M; García-Caballero T; Antúnez J; Couce M; Beiras A; Forteza J
    Histol Histopathol; 1993 Jul; 8(3):429-36. PubMed ID: 8358154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No correlation between phaeochromocytoma catecholamine secretion and granule ultrastructure.
    Mihai R; Wong NA; Luckett M; Sheffield E; Farndon JR
    Br J Surg; 1998 Dec; 85(12):1681-5. PubMed ID: 9876074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large dopamine-secreting pheochromocytoma: case report.
    Awada SH; Grisham A; Woods SE
    South Med J; 2003 Sep; 96(9):914-7. PubMed ID: 14513991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.
    Havekes B; van der Klaauw AA; Weiss MM; Jansen JC; van der Mey AG; Vriends AH; Bonsing BA; Romijn JA; Corssmit EP
    Endocr Relat Cancer; 2009 Jun; 16(2):527-36. PubMed ID: 19289533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion.
    Proye C; Fossati P; Fontaine P; Lefebvre J; Decoulx M; Wemeau JL; Dewailly D; Rwamasirabo E; Cecat P
    Surgery; 1986 Dec; 100(6):1154-62. PubMed ID: 3787474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low specificity of urinary 3-methoxytyramine in screening of dopamine-secreting pheochromocytomas and paragangliomas.
    Patin F; Crinière L; Francia T; Kassem S; Pierre P; Bruno C; Vayne C; Vourc'h P; Benz-de Bretagne I; Andres CR; Blasco H
    Clin Biochem; 2016 Oct; 49(15):1205-1208. PubMed ID: 27208558
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adrenal incidentaloma: a dopamine-secreting pheochromocytoma with an atypical clinical picture. A case report and review of the literature].
    Bartolacci M; Bartolacci S; Leombruni E; Annunziata A; Di Rienzo M; Picardi N
    Ann Ital Chir; 1998; 69(6):805-14. PubMed ID: 10213955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of and surgical therapy for pheochromocytoma and paraganglioma].
    Musholt TJ
    Zentralbl Chir; 2010 Jun; 135(3):226-32. PubMed ID: 20549585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of dopamine-secreting pheochromocytoma].
    Minamiguchi N; Inui E; Nukui M
    Hinyokika Kiyo; 1999 Dec; 45(12):831-3. PubMed ID: 10659416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paragangliomas: clinical overview.
    Young WF
    Ann N Y Acad Sci; 2006 Aug; 1073():21-9. PubMed ID: 17102068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic resection of abdominal paragangliomas.
    Mitchell J; Siperstein A; Milas M; Berber E
    Surg Laparosc Endosc Percutan Tech; 2011 Feb; 21(1):e48-53. PubMed ID: 21304376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas.
    van Houtum WH; Corssmit EP; Douwes Dekker PB; Jansen JC; van der Mey AG; Bröcker-Vriends AH; Taschner PE; Losekoot M; Frölich M; Stokkel MP; Cornelisse CJ; Romijn JA
    Eur J Endocrinol; 2005 Jan; 152(1):87-94. PubMed ID: 15762191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas.
    Lam KY; Lo CY; Wat NM; Luk JM; Lam KS
    J Clin Pathol; 2001 Jun; 54(6):443-8. PubMed ID: 11376017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phaeochromocytomas and paragangliomas: A difference in disease behaviour and clinical outcomes.
    Ezzat Abdel-Aziz T; Prete F; Conway G; Gaze M; Bomanji J; Bouloux P; Khoo B; Caplin M; Mushtaq I; Smart J; Kurzawinski TR
    J Surg Oncol; 2015 Oct; 112(5):486-91. PubMed ID: 26337393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of pheochromocytoma in childhood--case report].
    Kegel W
    Rontgenblatter; 1986 Jul; 39(7):188-90. PubMed ID: 3529343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
    Chrisoulidou A; Kaltsas G; Ilias I; Grossman AB
    Endocr Relat Cancer; 2007 Sep; 14(3):569-85. PubMed ID: 17914089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management for the removal of dopamin-secreting pheochromocytoma].
    Kamiutsuri K; Taki Y; Myojo Y; Tohyama K
    Masui; 2007 Feb; 56(2):186-9. PubMed ID: 17315737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phaeochromocytomas and functional paragangliomas: clinical management.
    Plouin PF; Amar L; Lepoutre C
    Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):933-41. PubMed ID: 21115162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.